Episodes

  • Pharma Pulse: Bipartisan 340B Law Introduced and Peak Rock's Specialty Pharmacy Bet

    Pharma Pulse: Bipartisan 340B Law Introduced and Peak Rock's Specialty Pharmacy Bet
    Jul 9 2026
    In this week's Pharma Pulse, lawmakers introduce comprehensive 340B legislation, Peak Rock Capital completes its acquisition of Asembia, and new LogiPharma data shows supply chain risks across the industry.
    Show More Show Less
    4 mins
  • Pharma Pulse: Medicare's GLP-1 Bridge and FDA's PreCheck Program

    Pharma Pulse: Medicare's GLP-1 Bridge and FDA's PreCheck Program
    Jul 1 2026
    This week's Pharma Pulse covers the launch of Medicare's GLP-1 Bridge, FDA's approval of the first regulatory T-cell therapy for chronic GVHD, seven companies tapped for FDA's PreCheck manufacturing pilot, and a wave of dealmaking.
    Show More Show Less
    4 mins
  • Pharma Pulse: UPS's Cold-Chain Buildout and AbbVie's $10.9B Immunology Bet

    Pharma Pulse: UPS's Cold-Chain Buildout and AbbVie's $10.9B Immunology Bet
    Jun 25 2026
    In this week's Pharma Pulse, UPS commits $48 million to cold-chain infrastructure, AbbVie moves to acquire Apogee Therapeutics in a $10.9 billion deal, and more.
    Show More Show Less
    4 mins
  • Pharma Pulse: What the USMCA Joint Review Means for Pharma

    Pharma Pulse: What the USMCA Joint Review Means for Pharma
    Jun 24 2026
    In this special episode of Pharma Pulse, Rohit Tripathi breaks down how companies should be scenario planning now, ahead of the first USMCA joint review which begins on July 1.
    Show More Show Less
    8 mins
  • Pharma Pulse: Drug Pricing Pressure in Europe and the New DSV Air Route

    Pharma Pulse: Drug Pricing Pressure in Europe and the New DSV Air Route
    Jun 17 2026
    In this week's Pharma Pulse, Europe’s drug pricing standoff intensifies, CMS moves to formalize Medicare negotiation rules, FDA expands OTC naloxone, and DSV launches a new pharma air route.
    Show More Show Less
    4 mins
  • Pharma Pulse: A Surge In Drug Discontinuations and Unapproved Retatrutide Prescriptions

    Pharma Pulse: A Surge In Drug Discontinuations and Unapproved Retatrutide Prescriptions
    Jun 11 2026
    In this week's Pharma Pulse, USP's annual shortages report reveals a sharp rise in drug discontinuations, J&J and Roche commit billions to protein degrader platforms, and more.
    Show More Show Less
    5 mins
  • Pharma Pulse: 340B Uncertainty, Drug Shortages, and Wegovy's Global Debut

    Pharma Pulse: 340B Uncertainty, Drug Shortages, and Wegovy's Global Debut
    Jun 4 2026
    In this week's Pharma Pulse, a Bluesight survey flags hospital pharmacy's top concerns, the Wegovy pill is introduced to the UAE, and more.
    Show More Show Less
    4 mins
  • Pharma Pulse: PBM Crackdowns and Lilly’s $3.8B Vaccine Spree

    Pharma Pulse: PBM Crackdowns and Lilly’s $3.8B Vaccine Spree
    May 28 2026
    In this week's Pharma Pulse, House committees advance key legislation targeting PBM kickbacks and pharmacy access, Macfarlane Packaging partners with eutecma to bring modular cold chain solutions to the UK, and more.
    Show More Show Less
    4 mins